VTGN VistaGen Therapeutics

VistaGen Therapeutics, Inc.
Companies
1993-2020
Filing Dates

444 filings

Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
4
Snodgrass H. Ralph
1 Jul 20
VistaGen Therapeutics / H. RALPH SNODGRASS ownership change
4
VTGN VistaGen Therapeutics, Inc.
1 Jul 20
VistaGen Therapeutics / Mark Alan Smith ownership change
4
VTGN VistaGen Therapeutics, Inc.
1 Jul 20
VistaGen Therapeutics / JERROLD DUANE DOTSON ownership change
4
Singh Shawn
1 Jul 20
VistaGen Therapeutics / Shawn Singh ownership change
8-K
VTGN VistaGen Therapeutics, Inc.
30 Jun 20
VistaGen Therapeutics Reports Fiscal Year 2020 Results and Provides CNS Pipeline Update
8-K
VTGN VistaGen Therapeutics, Inc.
26 Jun 20
Collaboration intended to support Phase 3 development and commercialization of PH94B in key Asian markets
8-K
VTGN VistaGen Therapeutics, Inc.
1 Jun 20
VistaGen and Nuformix Announce Agreement to Develop Novel Patentable Cocrystalline Forms of AV-101 for Treatment of Multiple CNS Conditions
8-K
VTGN VistaGen Therapeutics, Inc.
18 May 20
The Proposed Phase 2A Open-label Study will be Conducted in New York City
424B3
VTGN VistaGen Therapeutics, Inc.
15 May 20
Prospectus supplement
EFFECT
VTGN VistaGen Therapeutics, Inc.
14 May 20
Notice of effectiveness
S-3/A
VTGN VistaGen Therapeutics, Inc.
11 May 20
Shelf registration (amended)
CORRESP
VTGN VistaGen Therapeutics, Inc.
8 May 20
Correspondence with SEC
UPLOAD
VTGN VistaGen Therapeutics, Inc.
7 May 20
Letter from SEC
S-3
VTGN VistaGen Therapeutics, Inc.
1 May 20
Shelf registration
8-K
VTGN VistaGen Therapeutics, Inc.
28 Apr 20
VistaGen Expands PH94B Clinical Development to Include Adjustment Disorder Related to COVID-19
8-K
VTGN VistaGen Therapeutics, Inc.
27 Apr 20
Entry into a Material Definitive Agreement
4
VTGN VistaGen Therapeutics, Inc.
27 Apr 20
VistaGen Therapeutics / MARK A. MCPARTLAND ownership change
4
Dotson Jerrold Duane
27 Apr 20
VistaGen Therapeutics / JERROLD DUANE DOTSON ownership change
4
Smith Mark Alan
27 Apr 20
VistaGen Therapeutics / Mark Alan Smith ownership change
4
VTGN VistaGen Therapeutics, Inc.
27 Apr 20
VistaGen Therapeutics / H. RALPH SNODGRASS ownership change